Ticagrelor: A Reversible P2Y12 Inhibitor in Preventionof Thrombotic Events
Antiplatelet drugs play a crucial role in patients of coronary artery diseases, cerebrovascular diseases, and maintaining the patency of revascularised arteries and stents after coronary angioplasty. Ticagrelor is a new, reversible inhibitor of P2Y12, a purinergic adenosine di phosphate receptor pre...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sonali Sharma on behalf of Rajasthan University of Health Sciences
2023-09-01
|
| Series: | RUHS Journal of Health Sciences |
| Subjects: | |
| Online Access: | https://ruhsjhs.in/articleDetails.php?artid=TVRVeA== |